Lantmännen has signed an agreement to acquire HKScan Corporation’s Swedish operations, HKScan Sweden AB. The acquisition includes all operations in Sweden and the brands Scan, Pärsons and Bullens. The acquisition means that Lantmännen is broadening and strengthening its business portfolio from field to fork – and that long-term conditions for Swedish agriculture are strengthened.

HKScan’s Swedish operations offers meat- and plant-based food from Swedish farms, employs about 1,800 people, and in 2022 had net sales of approximately SEK 8 billion. The Swedish business has production facilities in Kristianstad, Skara, Linköping and Halmstad – and is Swedish headquarter in Stockholm.

In connection with the acquisition, Lantmännen also transfers all its existing shares in HKScan Corporation to HKScan Corporation. The transaction is subject to approval by relevant authorities, and is expected to be completed during the first half of 2024.  

Vinge’s team consisted of Christina Kokko, Karl Klackenberg, Clara Sohlberg and Robin Sultani (M&A), Johan Cederblad (Environment), Kristoffer Larson and Alexandra Tamm (Real Estate), Trine Osen Bergqvist and Jesper Ekman (Competition law), Malin Malm Waerme and Johan Gavelin (IP), Lisa Hörnqvist (GDPR), Eva Fredriksson, Jolene Reimerson and Carla Zachariasson (IT and Commercial Agreements), Mia Falk and Julia Löfquist (Regulatory), Agnes Pigg (Employment) and Emy Rydén (Transaction Support Coordinator).

Read the client's press release

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025